{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:05:19Z","timestamp":1783613119811,"version":"3.55.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Delirium represents a common and severe neuropsychiatric complication among critically ill individuals, often leading to extended hospital stays, elevated mortality risk, and persistent cognitive decline. Disruption of circadian sleep-wake rhythms is a major pathogenic factor, implying that melatonin may hold therapeutic potential in this context. Nonetheless, evidence regarding the effectiveness of melatonin in preventing delirium among patients in intensive care unit (ICU) remains inconsistent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This meta-analysis aimed to systematically evaluate the effects of melatonin and melatonin receptor agonists on the incidence and duration of delirium, length of ICU stay, and mortality among adult critically ill patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs). A comprehensive search was performed in PubMed, Embase, Scopus, and Cochrane CENTRAL from inception until 10 October 2025. Only RCTs comparing melatonin or ramelteon with placebo or standard care in adult ICU patients were included. The primary outcome was the incidence of delirium. Secondary outcomes included duration of delirium, length of ICU stay, and overall mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 22 RCTs involving 3706 patients were included. Pooled analysis demonstrated that melatonin administration was associated with a significant reduction in the incidence of delirium compared to the control group (Risk Ratio [RR] 0.75, 95% Confidence Interval [CI] 0.63 to 0.90, P = 0.001, I\n                      <jats:sup>2<\/jats:sup>\n                      = 50%). However, melatonin did not significantly affect the duration of delirium (Mean Difference [MD] 0.18 days, 95% CI -0.16 to 0.52, P = 0.56, I\n                      <jats:sup>2<\/jats:sup>\n                      = 45%), length of ICU stay (MD -0.45 days, 95% CI -1.10 to 0.20, P = 0.09, I\n                      <jats:sup>2<\/jats:sup>\n                      = 68%), or overall mortality (RR 0.92, 95% CI 0.79 to 1.06, P = 0.25, I\n                      <jats:sup>2<\/jats:sup>\n                      = 0%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Among critically ill adults, melatonin supplementation is effective in reducing the incidence of delirium. However, it does not appear to shorten the duration of delirium, reduce ICU stay, or improve survival. These findings support the use of melatonin for delirium prevention but suggest its benefits may be limited to reducing occurrence rather than altering the course of established delirium or other clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/osf.io\/95je7<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1728873","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:44:16Z","timestamp":1768196656000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Melatonin supplementation reduces delirium incidence in critically ill patients: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Xiaoyu","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panxin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haopeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhi","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"B1","first-page":"1571","article-title":"Potential role of exogenous melatonin supplement in delirium prevention in critically ill patients: a double-blind randomized pilot study","volume":"17","author":"Abbasi","year":"2018","journal-title":"Iran. J. Pharm. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e89480","DOI":"10.7759\/cureus.89480","article-title":"Efficacy and safety of ramelteon in the reduction of delirium and duration of ICU stay: a randomized placebo-controlled trial","volume":"17","author":"Akhileshwar","year":"2025","journal-title":"Cureus"},{"key":"B3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s40261-015-0368-5","article-title":"The safety of melatonin in humans","volume":"36","author":"Andersen","year":"2016","journal-title":"Clin. Drug Investig."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e20240144en","DOI":"10.62675\/2965-2774.20240144-en","article-title":"Efficacy of melatonin in decreasing the incidence of delirium in critically ill adults: a randomized controlled trial","volume":"36","author":"Bandyopadhyay","year":"2024","journal-title":"Crit. Care Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"R52","DOI":"10.1186\/cc6871","article-title":"Melatonin therapy to improve nocturnal sleep in critically ill patients: encouraging results from a small randomised controlled trial","volume":"12","author":"Bourne","year":"2008","journal-title":"Crit. Care"},{"key":"B6","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/j.1399-6576.2012.02672.x","article-title":"Sleep disturbances in critically ill patients in ICU: how much do we know?","volume":"56","author":"Boyko","year":"2012","journal-title":"Acta Anaesthesiol. Scand."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.chest.2024.12.030","article-title":"Low-dose melatonin for prevention of delirium in critically ill patients","volume":"167","author":"Burry","year":"2025","journal-title":"Chest"},{"key":"B8","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1210\/er.2018-00084","article-title":"Melatonin as a hormone: new physiological and clinical insights","volume":"39","author":"Cipolla-Neto","year":"2018","journal-title":"Endocr. Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","article-title":"Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU","volume":"46","author":"Devlin","year":"2018","journal-title":"Crit. Care Med."},{"key":"B10","first-page":"122","article-title":"Evaluating the potential effect of melatonin on the post-Cardiac surgery sleep disorder","volume":"10","author":"Dianatkhah","year":"2015","journal-title":"J. Tehran Heart Cent."},{"key":"B11","doi-asserted-by":"publisher","first-page":"814","DOI":"10.4103\/0019-5049.193664","article-title":"Effect of melatonin on duration of delirium in organophosphorus compound poisoning patients: a double-blind randomised placebo controlled trial","volume":"60","author":"Duggappa","year":"2016","journal-title":"Indian J. Anaesth."},{"key":"B12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341x.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"Bmj"},{"key":"B14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/jgs.16162","article-title":"The healthy heart\u2010mind trial: randomized controlled trial of melatonin for prevention of delirium","volume":"68","author":"Ford","year":"2019","journal-title":"J. Am. Geriatrics Soc."},{"key":"B15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/WNP.0000000000000110","article-title":"Sleep in the neurological intensive care unit: feasibility of quantifying sleep after melatonin supplementation with environmental light and noise reduction","volume":"32","author":"Foreman","year":"2015","journal-title":"J. Clin. Neurophysiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e1286","DOI":"10.1097\/CCM.0000000000004690","article-title":"The effects of melatonin supplementation on sleep quality and assessment of the serum melatonin in ICU patients: a randomized controlled trial","volume":"48","author":"Gandolfi","year":"2020","journal-title":"Crit. Care Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5847\/wjem.j.1920-8642.2021.02.006","article-title":"Poor outcomes of delirium in the intensive care units are amplified by increasing age: a retrospective cohort study","volume":"12","author":"Gao","year":"2021","journal-title":"World J. Emerg. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1001\/jamaneurol.2020.2273","article-title":"Association of delirium with long-term cognitive decline: a meta-analysis","volume":"77","author":"Goldberg","year":"2020","journal-title":"JAMA Neurol."},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.4103\/0019-5049.340654","article-title":"Evaluation of role of exogenous melatonin in prevention of delirium in postoperative patients admitted in intensive care unit: a randomised placebo-controlled study","volume":"66","author":"Gupta","year":"2022","journal-title":"Indian J. Anaesth."},{"key":"B20","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1001\/jamapsychiatry.2013.3320","article-title":"Preventive effects of ramelteon on delirium","volume":"71","author":"Hatta","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1177\/0885066620956622","article-title":"Epidemiology and predictors of long-stays in medical ICU: a retrospective cohort study","volume":"36","author":"Hermann","year":"2021","journal-title":"J. Intensive Care Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Bmj"},{"key":"B23","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1097\/CCM.0000000000006178","article-title":"Clinical impact of the implementation strategies used to apply the 2013 pain, agitation\/sedation, delirium or 2018 pain, agitation\/sedation, delirium, immobility, sleep disruption guideline recommendations: a systematic review and meta-analysis","volume":"52","author":"Hume","year":"2024","journal-title":"Crit. Care Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1097\/CCM.0000000000004004","article-title":"Ramelteon for prevention of postoperative delirium: a randomized controlled trial in patients undergoing elective pulmonary thromboendarterectomy","volume":"47","author":"Jaiswal","year":"2019","journal-title":"Crit. Care Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.30476\/ijms.2020.82860.1146","article-title":"Effect of melatonin on delirium after on-Pump coronary artery bypass graft surgery: a randomized clinical trial","volume":"46","author":"Javaherforoosh Zadeh","year":"2021","journal-title":"Iran. J. Med. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e138317","DOI":"10.5812\/aapm-138317","article-title":"The efficacy of dexmedetomidine alone or with melatonin on delirium after coronary artery bypass graft surgery: a randomized clinical trial","volume":"13","author":"Javaherforooshzadeh","year":"2023","journal-title":"Anesthesiol. Pain Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/CCM.0000000000000610","article-title":"Delirium transitions in the medical ICU: exploring the role of sleep quality and other factors","volume":"43","author":"Kamdar","year":"2015","journal-title":"Crit. Care Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3390\/antiox14070819","article-title":"Melatonin-A powerful antioxidant in neurodegenerative diseases","volume":"14","author":"Ko\u0142odziejska","year":"2025","journal-title":"Antioxidants (Basel)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00134-025-08143-1","article-title":"Melatonin and delirium in the intensive care units: a systematic review and meta-analysis of randomized controlled trials","volume":"51","author":"Lakbar","year":"2025","journal-title":"Intensive Care Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1080\/11101849.2021.1885956","article-title":"Postoperative delirium after coronary artery bypass graft surgery: dexmedetomidine infusion alone or with the addition of oral melatonin","volume":"37","author":"Mahrose","year":"2021","journal-title":"Egypt. J. Anaesth."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1007\/s00134-025-08002-z","article-title":"Melatonin for prevention of delirium in patients receiving mechanical ventilation in the intensive care unit: a multiarm multistage adaptive randomized controlled clinical trial (DEMEL)","volume":"51","author":"Mekontso Dessap","year":"2025","journal-title":"Intensive Care Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.22088\/cjim.13.1.51","article-title":"Effect of melatonin on stress-induced hyperglycemia and insulin resistance in critically-ill patients: a randomized double-blind, placebo-controlled clinical trial","volume":"13","author":"Naderi-Behdani","year":"2022","journal-title":"Casp. J. Intern Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00134-023-07029-4","article-title":"Long-term outcomes of intensive care unit delirium","volume":"49","author":"Nassar","year":"2023","journal-title":"Intensive Care Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"485","DOI":"10.7326\/M19-1860","article-title":"Antipsychotics for treating delirium in hospitalized adults: a systematic review","volume":"171","author":"Nikooie","year":"2019","journal-title":"Ann. Intern Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1097\/CCM.0000000000003132","article-title":"Effect of administration of ramelteon, a melatonin receptor agonist, on the duration of stay in the ICU: a single-center randomized placebo-controlled trial","volume":"46","author":"Nishikimi","year":"2018","journal-title":"Crit. Care Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1097\/MCC.0000000000000762","article-title":"Assessment and management of agitation, sleep, and mental illness in the surgical ICU","volume":"26","author":"Ortiz","year":"2020","journal-title":"Curr. Opin. Crit. Care"},{"key":"B37","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B38","doi-asserted-by":"publisher","first-page":"101802","DOI":"10.1016\/j.smrv.2023.101802","article-title":"Comment on Yang et al., 2020: Melatonergic agents in the prevention of delirium: a network meta-analysis of randomized controlled trials","volume":"70","author":"Rodrigues","year":"2020","journal-title":"Sleep. Med. Rev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"h2538","DOI":"10.1136\/bmj.h2538","article-title":"Outcome of delirium in critically ill patients: systematic review and meta-analysis","volume":"350","author":"Salluh","year":"2015","journal-title":"Bmj"},{"key":"B40","doi-asserted-by":"publisher","first-page":"E893","DOI":"10.1532\/hsf.4049","article-title":"Effects of melatonin on postoperative delirium after PCI in elderly patients: a randomized, single-center, double-blind, placebo-controlled trial","volume":"24","author":"Shi","year":"2021","journal-title":"Heart Surg. Forum"},{"key":"B41","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Bmj"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00134-021-06503-1","article-title":"Delirium in critical illness: clinical manifestations, outcomes, and management","volume":"47","author":"Stollings","year":"2021","journal-title":"Intensive Care Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e1714","DOI":"10.1097\/CCM.0000000000006767","article-title":"Melatonin use in the ICU: a systematic review and meta-analysis","volume":"53","author":"Tang","year":"2025","journal-title":"Crit. Care Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13613-022-01038-0","article-title":"Chronic critical illness and post-intensive care syndrome: from pathophysiology to clinical challenges","volume":"12","author":"Voiriot","year":"2022","journal-title":"Ann. Intensive Care"},{"key":"B45","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.genhosppsych.2023.08.011","article-title":"Efficacy and moderators of prevention and treatment of delirium with melatonin receptor agonists: a systematic review and meta-analysis of randomized controlled trials","volume":"85","author":"Wada","year":"2023","journal-title":"Gen. Hosp. Psychiatry"},{"key":"B46","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s00134-022-06638-9","article-title":"Prophylactic melatonin for delirium in intensive care (Pro-MEDIC): a randomized controlled trial","volume":"48","author":"Wibrow","year":"2022","journal-title":"Intensive Care Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"n1007","DOI":"10.1136\/bmj.n1007","article-title":"Delirium and long term cognition in critically ill patients","volume":"373","author":"Wilcox","year":"2021","journal-title":"Bmj"},{"key":"B48","doi-asserted-by":"publisher","first-page":"101235","DOI":"10.1016\/j.smrv.2019.101235","article-title":"Melatonergic agents in the prevention of delirium: a network meta-analysis of randomized controlled trials","volume":"50","author":"Yang","year":"2020","journal-title":"Sleep. Med. Rev."},{"key":"B49","doi-asserted-by":"publisher","first-page":"E037","DOI":"10.1532\/hsf.4325","article-title":"Effects of melatonin for delirium in elderly acute heart failure patients: a randomized, single-center, double-blind, and placebo-controlled trial","volume":"25","author":"Yin","year":"2022","journal-title":"Heart Surg. Forum"},{"key":"B50","first-page":"456","article-title":"Preventive effects of melatonin on delirium in intensive care unit patients: a meta-analysis of randomized controlled trials","volume":"30","author":"Zhao","year":"2024","journal-title":"Altern. Ther. Health Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1111\/bph.14116","article-title":"New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation","volume":"175","author":"Zisapel","year":"2018","journal-title":"Br. J. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1728873\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:44:22Z","timestamp":1768196662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1728873\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":51,"alternative-id":["10.3389\/fphar.2026.1728873"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1728873","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"article-number":"1728873"}}